MétaCan
Menu
Back to cohort
Record W2094409037 · doi:10.1177/0091270005283285

Challenges and Opportunities for Pharmacoepidemiology in Drug‐Therapy Decision Making

2006· article· en· W2094409037 on OpenAlexaff
Mahyar Etminan, Sudeep S. Gill, Mark Fitzgerald, Ali Samii

Bibliographic record

VenueThe Journal of Clinical Pharmacology · 2006
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmacovigilance and Adverse Drug Reactions
Canadian institutionsUniversity of British ColumbiaQueen's UniversityCentre for Advancing Health OutcomesRoyal Victoria Hospital
Fundersnot available
KeywordsPharmacoepidemiologyMedicineAdverse effectDrugIntensive care medicinePopulationDrug reactionMEDLINEAlternative medicineRandomized controlled trialClinical study designAdverse drug reactionClinical trialPharmacologyInternal medicinePathologyEnvironmental health

Abstract

fetched live from OpenAlex

Pharmacoepidemiology is a relatively new and evolving science that attempts to quantify mainly adverse drug events and patterns of drug use in a large population. The strength of pharmacoepidemiology over randomized trials is the ability to quantify rare adverse events that may occur over long periods. Recently, discordance in the results of pharmacoepidemiologic studies has made it difficult for clinicians and policy makers to make informed drug-therapy decisions. This commentary addresses the strength of pharmacoepidemiology and the advances in the methodology of pharmacoepidemiologic studies over the years. We also discuss the potential problem of discordant results and urge pharmacoepidemiologists to develop good practice guidelines for the conduct of pharmacoepidemiologic studies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.505
metaresearch head score (Gemma)0.501
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.505
Threshold uncertainty score0.611

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.5050.501
Meta-epidemiology (narrow)0.0020.003
Meta-epidemiology (broad)0.0080.004
Bibliometrics0.0090.005
Science and technology studies0.0070.041
Scholarly communication0.0280.039
Open science0.0120.020
Research integrity0.0270.047
Insufficient payload (model declined to judge)0.0080.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.568
GPT teacher head0.597
Teacher spread0.029 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations30
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Clinical PharmacologySame topicPharmacovigilance and Adverse Drug ReactionsFrench-language works237,207